Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Immunotech Biopharm Ltd ( (HK:6978) ) has shared an update.
Immunotech Biopharm Ltd announced the resignation of Dr. Wang Yu from her roles as executive director, CEO, and CTO, effective June 25, 2025, due to disagreements with the board over governance issues. The board has appointed Mr. Zhang Jian as acting CEO and is actively seeking suitable candidates to fill the vacant positions, maintaining that the company’s operations remain unchanged.
More about Immunotech Biopharm Ltd
Immunotech Biopharm Ltd is a company incorporated in the Cayman Islands, focusing on biopharmaceuticals. The company, along with its subsidiaries, operates in the biotechnology industry, primarily offering innovative medical solutions.
Average Trading Volume: 556,186
Technical Sentiment Signal: Sell
Current Market Cap: HK$1.56B
Learn more about 6978 stock on TipRanks’ Stock Analysis page.